Alan S. L. Yu
Has grant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Structure-Function Studies of Tight Junction Membrane Proteins
Open Date: 2010-09-30
Close Date: 2015-06-30
Grant: Close
Sodium-chloride co-transporter regulation in the kidney
Open Date: 2010-08-01
Close Date: 2011-07-31
Grant: Close
University of Kansas Training Grant in Nephrology
Open Date: 2005-07-01
Close Date: 2017-06-30
Grant: Close
Expression, function and regulation of renal claudins
Open Date: 2002-07-01
Close Date: 2013-05-31
Grant: Close
Kansas Polycystic Kidney Imaging Program
Open Date: 2000-02-01
Close Date: 2016-05-31
Articles (11)
Claudin-2 is a tight junction protein expressed in leaky epithelia where it forms paracellular pores permeable to cations and water. The paracellular pore formed by claudin-2 is important in energy-efficient cation and water transport in the proximal tubules of the kidneys. Mounting evidence now suggests that claudin-2 may modulate cellular processes often altered in disease, including cellular proliferation. Also, dysregulation of claudin-2 expression has been linked to various diseases, including kidney stone disease and renal cell carcinoma. However, the mechanisms linking altered claudin-2 expression and function to disease are poorly understood and require further investigation. The aim of this review is to discuss the current understanding of the role of claudin-2 in kidney function and dysfunction. We provide a general overview of the claudins and their organization in the tight junction, the expression, and function of claudin-2 in the kidney, and the evolving evidence for its role in kidney disease.
Year:
2023
To our knowledge, this study is the first to generate urinary global metabolomic profiles from individuals with early-stage ADPKD with preserved renal function for biomarker discovery. The exploratory dataset reveals metabolic pathway alterations that may be responsible for early cystogenesis and rapid disease progression and may be potential therapeutic targets and pathway sources for candidate biomarkers. From these results, we generated a panel of candidate diagnostic and prognostic biomarkers of early-stage ADPKD for future validation.
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Collaborators (7)
Ronald K. June
Montana State University
Ronald D. Perrone
Tufts University School of Medicine
Mei Liu
Associate Professor
University of Florida
Gunda Georg
Regents Professor and Department Head
University of Minnesota System
Michael Matheny
Associate Professor
Vanderbilt University Medical Center
Alyssa K. Hahn
-
Xing Song
Assistant Professor
University of Missouri
Make your next move.
Prepare your application
Review drafts before you send them.